The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Cyanocobalamin Injection Market Research Report 2024
Synopsis
Cyanocobalamin is a man-made form of vitamin B12 used to prevent and treat low blood levels of this vitamin. Most people get enough vitamin B12 from their diet. Vitamin B12 is important to maintain the health of your metabolism, blood cells, and nerves.
The global Cyanocobalamin Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Cyanocobalamin Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cyanocobalamin Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Cyanocobalamin Injection include Luitpold Pharmaceuticals, Luitpold Pharmaceuticals(Daiichi Sankyo), Endo International, Bristol-Myers Squibb, Sanofi-Aventis, Jamieson, Teva(Actavis), Merck and Mylan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cyanocobalamin Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cyanocobalamin Injection.
Report Scope
The Cyanocobalamin Injection market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cyanocobalamin Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cyanocobalamin Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Luitpold Pharmaceuticals
Luitpold Pharmaceuticals(Daiichi Sankyo)
Endo International
Bristol-Myers Squibb
Sanofi-Aventis
Jamieson
Teva(Actavis)
Merck
Mylan
Bayer HealthCare
Pfizer
ANGELINI
Biological E
CCEPCD
Huaxin Pharmaceutical
Segment by Type
Vitamins
Supplements
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cyanocobalamin Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cyanocobalamin Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Cyanocobalamin is a man-made form of vitamin B12 used to prevent and treat low blood levels of this vitamin. Most people get enough vitamin B12 from their diet. Vitamin B12 is important to maintain the health of your metabolism, blood cells, and nerves.
The global Cyanocobalamin Injection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Cyanocobalamin Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Cyanocobalamin Injection is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Cyanocobalamin Injection include Luitpold Pharmaceuticals, Luitpold Pharmaceuticals(Daiichi Sankyo), Endo International, Bristol-Myers Squibb, Sanofi-Aventis, Jamieson, Teva(Actavis), Merck and Mylan, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Cyanocobalamin Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cyanocobalamin Injection.
Report Scope
The Cyanocobalamin Injection market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Cyanocobalamin Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cyanocobalamin Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Luitpold Pharmaceuticals
Luitpold Pharmaceuticals(Daiichi Sankyo)
Endo International
Bristol-Myers Squibb
Sanofi-Aventis
Jamieson
Teva(Actavis)
Merck
Mylan
Bayer HealthCare
Pfizer
ANGELINI
Biological E
CCEPCD
Huaxin Pharmaceutical
Segment by Type
Vitamins
Supplements
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Cyanocobalamin Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Cyanocobalamin Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Cyanocobalamin Injection Market Overview
1.1 Product Overview and Scope of Cyanocobalamin Injection
1.2 Cyanocobalamin Injection Segment by Type
1.2.1 Global Cyanocobalamin Injection Market Value Comparison by Type (2024-2030)
1.2.2 Vitamins
1.2.3 Supplements
1.3 Cyanocobalamin Injection Segment by Application
1.3.1 Global Cyanocobalamin Injection Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Cyanocobalamin Injection Market Size Estimates and Forecasts
1.4.1 Global Cyanocobalamin Injection Revenue 2019-2030
1.4.2 Global Cyanocobalamin Injection Sales 2019-2030
1.4.3 Global Cyanocobalamin Injection Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Cyanocobalamin Injection Market Competition by Manufacturers
2.1 Global Cyanocobalamin Injection Sales Market Share by Manufacturers (2019-2024)
2.2 Global Cyanocobalamin Injection Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Cyanocobalamin Injection Average Price by Manufacturers (2019-2024)
2.4 Global Cyanocobalamin Injection Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cyanocobalamin Injection, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cyanocobalamin Injection, Product Type & Application
2.7 Cyanocobalamin Injection Market Competitive Situation and Trends
2.7.1 Cyanocobalamin Injection Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Cyanocobalamin Injection Players Market Share by Revenue
2.7.3 Global Cyanocobalamin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Cyanocobalamin Injection Retrospective Market Scenario by Region
3.1 Global Cyanocobalamin Injection Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Cyanocobalamin Injection Global Cyanocobalamin Injection Sales by Region: 2019-2030
3.2.1 Global Cyanocobalamin Injection Sales by Region: 2019-2024
3.2.2 Global Cyanocobalamin Injection Sales by Region: 2025-2030
3.3 Global Cyanocobalamin Injection Global Cyanocobalamin Injection Revenue by Region: 2019-2030
3.3.1 Global Cyanocobalamin Injection Revenue by Region: 2019-2024
3.3.2 Global Cyanocobalamin Injection Revenue by Region: 2025-2030
3.4 North America Cyanocobalamin Injection Market Facts & Figures by Country
3.4.1 North America Cyanocobalamin Injection Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Cyanocobalamin Injection Sales by Country (2019-2030)
3.4.3 North America Cyanocobalamin Injection Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Cyanocobalamin Injection Market Facts & Figures by Country
3.5.1 Europe Cyanocobalamin Injection Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Cyanocobalamin Injection Sales by Country (2019-2030)
3.5.3 Europe Cyanocobalamin Injection Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cyanocobalamin Injection Market Facts & Figures by Country
3.6.1 Asia Pacific Cyanocobalamin Injection Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Cyanocobalamin Injection Sales by Country (2019-2030)
3.6.3 Asia Pacific Cyanocobalamin Injection Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Cyanocobalamin Injection Market Facts & Figures by Country
3.7.1 Latin America Cyanocobalamin Injection Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Cyanocobalamin Injection Sales by Country (2019-2030)
3.7.3 Latin America Cyanocobalamin Injection Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cyanocobalamin Injection Market Facts & Figures by Country
3.8.1 Middle East and Africa Cyanocobalamin Injection Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Cyanocobalamin Injection Sales by Country (2019-2030)
3.8.3 Middle East and Africa Cyanocobalamin Injection Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Cyanocobalamin Injection Sales by Type (2019-2030)
4.1.1 Global Cyanocobalamin Injection Sales by Type (2019-2024)
4.1.2 Global Cyanocobalamin Injection Sales by Type (2025-2030)
4.1.3 Global Cyanocobalamin Injection Sales Market Share by Type (2019-2030)
4.2 Global Cyanocobalamin Injection Revenue by Type (2019-2030)
4.2.1 Global Cyanocobalamin Injection Revenue by Type (2019-2024)
4.2.2 Global Cyanocobalamin Injection Revenue by Type (2025-2030)
4.2.3 Global Cyanocobalamin Injection Revenue Market Share by Type (2019-2030)
4.3 Global Cyanocobalamin Injection Price by Type (2019-2030)
5 Segment by Application
5.1 Global Cyanocobalamin Injection Sales by Application (2019-2030)
5.1.1 Global Cyanocobalamin Injection Sales by Application (2019-2024)
5.1.2 Global Cyanocobalamin Injection Sales by Application (2025-2030)
5.1.3 Global Cyanocobalamin Injection Sales Market Share by Application (2019-2030)
5.2 Global Cyanocobalamin Injection Revenue by Application (2019-2030)
5.2.1 Global Cyanocobalamin Injection Revenue by Application (2019-2024)
5.2.2 Global Cyanocobalamin Injection Revenue by Application (2025-2030)
5.2.3 Global Cyanocobalamin Injection Revenue Market Share by Application (2019-2030)
5.3 Global Cyanocobalamin Injection Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Luitpold Pharmaceuticals
6.1.1 Luitpold Pharmaceuticals Corporation Information
6.1.2 Luitpold Pharmaceuticals Description and Business Overview
6.1.3 Luitpold Pharmaceuticals Cyanocobalamin Injection Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Luitpold Pharmaceuticals Cyanocobalamin Injection Product Portfolio
6.1.5 Luitpold Pharmaceuticals Recent Developments/Updates
6.2 Luitpold Pharmaceuticals(Daiichi Sankyo)
6.2.1 Luitpold Pharmaceuticals(Daiichi Sankyo) Corporation Information
6.2.2 Luitpold Pharmaceuticals(Daiichi Sankyo) Description and Business Overview
6.2.3 Luitpold Pharmaceuticals(Daiichi Sankyo) Cyanocobalamin Injection Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Luitpold Pharmaceuticals(Daiichi Sankyo) Cyanocobalamin Injection Product Portfolio
6.2.5 Luitpold Pharmaceuticals(Daiichi Sankyo) Recent Developments/Updates
6.3 Endo International
6.3.1 Endo International Corporation Information
6.3.2 Endo International Description and Business Overview
6.3.3 Endo International Cyanocobalamin Injection Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Endo International Cyanocobalamin Injection Product Portfolio
6.3.5 Endo International Recent Developments/Updates
6.4 Bristol-Myers Squibb
6.4.1 Bristol-Myers Squibb Corporation Information
6.4.2 Bristol-Myers Squibb Description and Business Overview
6.4.3 Bristol-Myers Squibb Cyanocobalamin Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Bristol-Myers Squibb Cyanocobalamin Injection Product Portfolio
6.4.5 Bristol-Myers Squibb Recent Developments/Updates
6.5 Sanofi-Aventis
6.5.1 Sanofi-Aventis Corporation Information
6.5.2 Sanofi-Aventis Description and Business Overview
6.5.3 Sanofi-Aventis Cyanocobalamin Injection Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sanofi-Aventis Cyanocobalamin Injection Product Portfolio
6.5.5 Sanofi-Aventis Recent Developments/Updates
6.6 Jamieson
6.6.1 Jamieson Corporation Information
6.6.2 Jamieson Description and Business Overview
6.6.3 Jamieson Cyanocobalamin Injection Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Jamieson Cyanocobalamin Injection Product Portfolio
6.6.5 Jamieson Recent Developments/Updates
6.7 Teva(Actavis)
6.6.1 Teva(Actavis) Corporation Information
6.6.2 Teva(Actavis) Description and Business Overview
6.6.3 Teva(Actavis) Cyanocobalamin Injection Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva(Actavis) Cyanocobalamin Injection Product Portfolio
6.7.5 Teva(Actavis) Recent Developments/Updates
6.8 Merck
6.8.1 Merck Corporation Information
6.8.2 Merck Description and Business Overview
6.8.3 Merck Cyanocobalamin Injection Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Merck Cyanocobalamin Injection Product Portfolio
6.8.5 Merck Recent Developments/Updates
6.9 Mylan
6.9.1 Mylan Corporation Information
6.9.2 Mylan Description and Business Overview
6.9.3 Mylan Cyanocobalamin Injection Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Mylan Cyanocobalamin Injection Product Portfolio
6.9.5 Mylan Recent Developments/Updates
6.10 Bayer HealthCare
6.10.1 Bayer HealthCare Corporation Information
6.10.2 Bayer HealthCare Description and Business Overview
6.10.3 Bayer HealthCare Cyanocobalamin Injection Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bayer HealthCare Cyanocobalamin Injection Product Portfolio
6.10.5 Bayer HealthCare Recent Developments/Updates
6.11 Pfizer
6.11.1 Pfizer Corporation Information
6.11.2 Pfizer Cyanocobalamin Injection Description and Business Overview
6.11.3 Pfizer Cyanocobalamin Injection Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Pfizer Cyanocobalamin Injection Product Portfolio
6.11.5 Pfizer Recent Developments/Updates
6.12 ANGELINI
6.12.1 ANGELINI Corporation Information
6.12.2 ANGELINI Cyanocobalamin Injection Description and Business Overview
6.12.3 ANGELINI Cyanocobalamin Injection Sales, Revenue and Gross Margin (2019-2024)
6.12.4 ANGELINI Cyanocobalamin Injection Product Portfolio
6.12.5 ANGELINI Recent Developments/Updates
6.13 Biological E
6.13.1 Biological E Corporation Information
6.13.2 Biological E Cyanocobalamin Injection Description and Business Overview
6.13.3 Biological E Cyanocobalamin Injection Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Biological E Cyanocobalamin Injection Product Portfolio
6.13.5 Biological E Recent Developments/Updates
6.14 CCEPCD
6.14.1 CCEPCD Corporation Information
6.14.2 CCEPCD Cyanocobalamin Injection Description and Business Overview
6.14.3 CCEPCD Cyanocobalamin Injection Sales, Revenue and Gross Margin (2019-2024)
6.14.4 CCEPCD Cyanocobalamin Injection Product Portfolio
6.14.5 CCEPCD Recent Developments/Updates
6.15 Huaxin Pharmaceutical
6.15.1 Huaxin Pharmaceutical Corporation Information
6.15.2 Huaxin Pharmaceutical Cyanocobalamin Injection Description and Business Overview
6.15.3 Huaxin Pharmaceutical Cyanocobalamin Injection Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Huaxin Pharmaceutical Cyanocobalamin Injection Product Portfolio
6.15.5 Huaxin Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cyanocobalamin Injection Industry Chain Analysis
7.2 Cyanocobalamin Injection Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cyanocobalamin Injection Production Mode & Process
7.4 Cyanocobalamin Injection Sales and Marketing
7.4.1 Cyanocobalamin Injection Sales Channels
7.4.2 Cyanocobalamin Injection Distributors
7.5 Cyanocobalamin Injection Customers
8 Cyanocobalamin Injection Market Dynamics
8.1 Cyanocobalamin Injection Industry Trends
8.2 Cyanocobalamin Injection Market Drivers
8.3 Cyanocobalamin Injection Market Challenges
8.4 Cyanocobalamin Injection Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Cyanocobalamin Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Cyanocobalamin Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Cyanocobalamin Injection Market Competitive Situation by Manufacturers in 2023
Table 4. Global Cyanocobalamin Injection Sales (K Doses) of Key Manufacturers (2019-2024)
Table 5. Global Cyanocobalamin Injection Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Cyanocobalamin Injection Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Cyanocobalamin Injection Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Cyanocobalamin Injection Average Price (USD/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Cyanocobalamin Injection, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Cyanocobalamin Injection, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Cyanocobalamin Injection, Product Type & Application
Table 12. Global Key Manufacturers of Cyanocobalamin Injection, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Cyanocobalamin Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cyanocobalamin Injection as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Cyanocobalamin Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Cyanocobalamin Injection Sales by Region (2019-2024) & (K Doses)
Table 18. Global Cyanocobalamin Injection Sales Market Share by Region (2019-2024)
Table 19. Global Cyanocobalamin Injection Sales by Region (2025-2030) & (K Doses)
Table 20. Global Cyanocobalamin Injection Sales Market Share by Region (2025-2030)
Table 21. Global Cyanocobalamin Injection Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Cyanocobalamin Injection Revenue Market Share by Region (2019-2024)
Table 23. Global Cyanocobalamin Injection Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Cyanocobalamin Injection Revenue Market Share by Region (2025-2030)
Table 25. North America Cyanocobalamin Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Cyanocobalamin Injection Sales by Country (2019-2024) & (K Doses)
Table 27. North America Cyanocobalamin Injection Sales by Country (2025-2030) & (K Doses)
Table 28. North America Cyanocobalamin Injection Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Cyanocobalamin Injection Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Cyanocobalamin Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Cyanocobalamin Injection Sales by Country (2019-2024) & (K Doses)
Table 32. Europe Cyanocobalamin Injection Sales by Country (2025-2030) & (K Doses)
Table 33. Europe Cyanocobalamin Injection Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Cyanocobalamin Injection Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Cyanocobalamin Injection Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Cyanocobalamin Injection Sales by Region (2019-2024) & (K Doses)
Table 37. Asia Pacific Cyanocobalamin Injection Sales by Region (2025-2030) & (K Doses)
Table 38. Asia Pacific Cyanocobalamin Injection Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Cyanocobalamin Injection Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Cyanocobalamin Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Cyanocobalamin Injection Sales by Country (2019-2024) & (K Doses)
Table 42. Latin America Cyanocobalamin Injection Sales by Country (2025-2030) & (K Doses)
Table 43. Latin America Cyanocobalamin Injection Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Cyanocobalamin Injection Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Cyanocobalamin Injection Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Cyanocobalamin Injection Sales by Country (2019-2024) & (K Doses)
Table 47. Middle East & Africa Cyanocobalamin Injection Sales by Country (2025-2030) & (K Doses)
Table 48. Middle East & Africa Cyanocobalamin Injection Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Cyanocobalamin Injection Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Cyanocobalamin Injection Sales (K Doses) by Type (2019-2024)
Table 51. Global Cyanocobalamin Injection Sales (K Doses) by Type (2025-2030)
Table 52. Global Cyanocobalamin Injection Sales Market Share by Type (2019-2024)
Table 53. Global Cyanocobalamin Injection Sales Market Share by Type (2025-2030)
Table 54. Global Cyanocobalamin Injection Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Cyanocobalamin Injection Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Cyanocobalamin Injection Revenue Market Share by Type (2019-2024)
Table 57. Global Cyanocobalamin Injection Revenue Market Share by Type (2025-2030)
Table 58. Global Cyanocobalamin Injection Price (USD/Dose) by Type (2019-2024)
Table 59. Global Cyanocobalamin Injection Price (USD/Dose) by Type (2025-2030)
Table 60. Global Cyanocobalamin Injection Sales (K Doses) by Application (2019-2024)
Table 61. Global Cyanocobalamin Injection Sales (K Doses) by Application (2025-2030)
Table 62. Global Cyanocobalamin Injection Sales Market Share by Application (2019-2024)
Table 63. Global Cyanocobalamin Injection Sales Market Share by Application (2025-2030)
Table 64. Global Cyanocobalamin Injection Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Cyanocobalamin Injection Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Cyanocobalamin Injection Revenue Market Share by Application (2019-2024)
Table 67. Global Cyanocobalamin Injection Revenue Market Share by Application (2025-2030)
Table 68. Global Cyanocobalamin Injection Price (USD/Dose) by Application (2019-2024)
Table 69. Global Cyanocobalamin Injection Price (USD/Dose) by Application (2025-2030)
Table 70. Luitpold Pharmaceuticals Corporation Information
Table 71. Luitpold Pharmaceuticals Description and Business Overview
Table 72. Luitpold Pharmaceuticals Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 73. Luitpold Pharmaceuticals Cyanocobalamin Injection Product
Table 74. Luitpold Pharmaceuticals Recent Developments/Updates
Table 75. Luitpold Pharmaceuticals(Daiichi Sankyo) Corporation Information
Table 76. Luitpold Pharmaceuticals(Daiichi Sankyo) Description and Business Overview
Table 77. Luitpold Pharmaceuticals(Daiichi Sankyo) Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 78. Luitpold Pharmaceuticals(Daiichi Sankyo) Cyanocobalamin Injection Product
Table 79. Luitpold Pharmaceuticals(Daiichi Sankyo) Recent Developments/Updates
Table 80. Endo International Corporation Information
Table 81. Endo International Description and Business Overview
Table 82. Endo International Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 83. Endo International Cyanocobalamin Injection Product
Table 84. Endo International Recent Developments/Updates
Table 85. Bristol-Myers Squibb Corporation Information
Table 86. Bristol-Myers Squibb Description and Business Overview
Table 87. Bristol-Myers Squibb Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 88. Bristol-Myers Squibb Cyanocobalamin Injection Product
Table 89. Bristol-Myers Squibb Recent Developments/Updates
Table 90. Sanofi-Aventis Corporation Information
Table 91. Sanofi-Aventis Description and Business Overview
Table 92. Sanofi-Aventis Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 93. Sanofi-Aventis Cyanocobalamin Injection Product
Table 94. Sanofi-Aventis Recent Developments/Updates
Table 95. Jamieson Corporation Information
Table 96. Jamieson Description and Business Overview
Table 97. Jamieson Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 98. Jamieson Cyanocobalamin Injection Product
Table 99. Jamieson Recent Developments/Updates
Table 100. Teva(Actavis) Corporation Information
Table 101. Teva(Actavis) Description and Business Overview
Table 102. Teva(Actavis) Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 103. Teva(Actavis) Cyanocobalamin Injection Product
Table 104. Teva(Actavis) Recent Developments/Updates
Table 105. Merck Corporation Information
Table 106. Merck Description and Business Overview
Table 107. Merck Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 108. Merck Cyanocobalamin Injection Product
Table 109. Merck Recent Developments/Updates
Table 110. Mylan Corporation Information
Table 111. Mylan Description and Business Overview
Table 112. Mylan Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 113. Mylan Cyanocobalamin Injection Product
Table 114. Mylan Recent Developments/Updates
Table 115. Bayer HealthCare Corporation Information
Table 116. Bayer HealthCare Description and Business Overview
Table 117. Bayer HealthCare Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 118. Bayer HealthCare Cyanocobalamin Injection Product
Table 119. Bayer HealthCare Recent Developments/Updates
Table 120. Pfizer Corporation Information
Table 121. Pfizer Description and Business Overview
Table 122. Pfizer Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 123. Pfizer Cyanocobalamin Injection Product
Table 124. Pfizer Recent Developments/Updates
Table 125. ANGELINI Corporation Information
Table 126. ANGELINI Description and Business Overview
Table 127. ANGELINI Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 128. ANGELINI Cyanocobalamin Injection Product
Table 129. ANGELINI Recent Developments/Updates
Table 130. Biological E Corporation Information
Table 131. Biological E Description and Business Overview
Table 132. Biological E Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 133. Biological E Cyanocobalamin Injection Product
Table 134. Biological E Recent Developments/Updates
Table 135. CCEPCD Corporation Information
Table 136. CCEPCD Description and Business Overview
Table 137. CCEPCD Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 138. CCEPCD Cyanocobalamin Injection Product
Table 139. CCEPCD Recent Developments/Updates
Table 140. Huaxin Pharmaceutical Corporation Information
Table 141. Huaxin Pharmaceutical Description and Business Overview
Table 142. Huaxin Pharmaceutical Cyanocobalamin Injection Sales (K Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2019-2024)
Table 143. Huaxin Pharmaceutical Cyanocobalamin Injection Product
Table 144. Huaxin Pharmaceutical Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Cyanocobalamin Injection Distributors List
Table 148. Cyanocobalamin Injection Customers List
Table 149. Cyanocobalamin Injection Market Trends
Table 150. Cyanocobalamin Injection Market Drivers
Table 151. Cyanocobalamin Injection Market Challenges
Table 152. Cyanocobalamin Injection Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Cyanocobalamin Injection
Figure 2. Global Cyanocobalamin Injection Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Cyanocobalamin Injection Market Share by Type in 2023 & 2030
Figure 4. Vitamins Product Picture
Figure 5. Supplements Product Picture
Figure 6. Global Cyanocobalamin Injection Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Cyanocobalamin Injection Market Share by Application in 2023 & 2030
Figure 8. Hospitals
Figure 9. Clinics
Figure 10. Others
Figure 11. Global Cyanocobalamin Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Cyanocobalamin Injection Market Size (2019-2030) & (US$ Million)
Figure 13. Global Cyanocobalamin Injection Sales (2019-2030) & (K Doses)
Figure 14. Global Cyanocobalamin Injection Average Price (USD/Dose) & (2019-2030)
Figure 15. Cyanocobalamin Injection Report Years Considered
Figure 16. Cyanocobalamin Injection Sales Share by Manufacturers in 2023
Figure 17. Global Cyanocobalamin Injection Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Cyanocobalamin Injection Players: Market Share by Revenue in 2023
Figure 19. Cyanocobalamin Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Cyanocobalamin Injection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Cyanocobalamin Injection Sales Market Share by Country (2019-2030)
Figure 22. North America Cyanocobalamin Injection Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Cyanocobalamin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Cyanocobalamin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Cyanocobalamin Injection Sales Market Share by Country (2019-2030)
Figure 26. Europe Cyanocobalamin Injection Revenue Market Share by Country (2019-2030)
Figure 27. Germany Cyanocobalamin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Cyanocobalamin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Cyanocobalamin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Cyanocobalamin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Cyanocobalamin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Cyanocobalamin Injection Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Cyanocobalamin Injection Revenue Market Share by Region (2019-2030)
Figure 34. China Cyanocobalamin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Cyanocobalamin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Cyanocobalamin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Cyanocobalamin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Cyanocobalamin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Cyanocobalamin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Cyanocobalamin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Cyanocobalamin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Cyanocobalamin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Cyanocobalamin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Cyanocobalamin Injection Sales Market Share by Country (2019-2030)
Figure 45. Latin America Cyanocobalamin Injection Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Cyanocobalamin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Cyanocobalamin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Cyanocobalamin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Cyanocobalamin Injection Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Cyanocobalamin Injection Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Cyanocobalamin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Cyanocobalamin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. U.A.E Cyanocobalamin Injection Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Cyanocobalamin Injection by Type (2019-2030)
Figure 55. Global Revenue Market Share of Cyanocobalamin Injection by Type (2019-2030)
Figure 56. Global Cyanocobalamin Injection Price (USD/Dose) by Type (2019-2030)
Figure 57. Global Sales Market Share of Cyanocobalamin Injection by Application (2019-2030)
Figure 58. Global Revenue Market Share of Cyanocobalamin Injection by Application (2019-2030)
Figure 59. Global Cyanocobalamin Injection Price (USD/Dose) by Application (2019-2030)
Figure 60. Cyanocobalamin Injection Value Chain
Figure 61. Cyanocobalamin Injection Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
